Table 1.
Characteristics of the study group included in the analysis of hyperuricemia for all analyzed subjects (N = 4028), and for men and women separately.
| All | Men N = 2101 (52.2%) |
Women N = 1927 (47.8%) |
|
|---|---|---|---|
| Age (years) | 79 ± 9 | 79 ± 8 | 79 ± 9 |
| 65–69 years, N (%) | 683 (16.9) | 327 (15.6) | 356 (18.5) |
| 70–74 years, N (%) | 778 (19.3) | 399 (19.0) | 379 (19.7) |
| 75–79 years, N (%) | 696 (17.3) | 372 (17.7) | 324 (16.8) |
| 80–84 years, N (%) | 627 (15.6) | 338 (16.1) | 289 (15.0) |
| 85–89 years, N (%) | 684 (17.0) | 387 (18.4) | 297 (15.4) |
| ≥90 years, N (%) | 560 (13.9) | 278 (13.2) | 282 (14.6) |
| Rural area residence, N (%) | 2395 (59.4) | 1254 (59.7) | 1141 (59.2) |
| Blue-collar, N (%) | 1365 (33.9) | 821 (39.1) | 544 (28.2) |
| White-collar, N (%) | 326 (8.1) | 216 (10.4) | 110 (5.8) |
| Living alone, N (%) | 816 (20.2) | 279 (13.4) | 537 (28.2) |
| Personal income | |||
| • Low, N (%) | 1433 (40.5) | 491 (26.9) | 942 (55.1) |
| • Average, N (%) | 1753 (49.6) | 1042 (57.0) | 711 (41.6) |
| • High, N (%) | 351 (9.9) | 294 (16.1) | 57 (3.3) |
| Vegetarian diet, N (%) | 57 (1.4) | 31 (1.5) | 26 (1.3) |
| Alcohol consumers “drinking”, N (%) | 628 (15.6) | 520 (25.1) | 108(5.7) |
| BMI (kg/m2) | 28.1 ± 5.0 | 27.4 ± 4.4 | 29.0 ± 5.5 |
| Overweight, N (%) | 1570 (41.2) | 912 (45.3) | 658 (36.5) |
| Obesity, N (%) | 1230 (32.2) | 512 (25.4) | 718 (39.8) |
| Visceral obesity, N (%) | 3158 (81.2) | 1505 (73.4) | 1653 (89.8) |
| Diabetes, N (%) | 925 (23.0) | 447 (21.3) | 478 (24.8) |
| Hypertension, N (%) | 2945 (73.4) | 1446 (69.1) | 1499 (78.1) |
| Coronary artery disease, N (%) | 865 (21.5) | 492 (23.4) | 373 (19.4) |
| Heart failure, N (%) | 243 (6.2) | 140 (6.8) | 103 (5.5) |
| Hypercholesterolemia, N (%) | 2973 (73.8) | 1408 (67.0) | 1565 (81.2) |
| Hypertriglyceridemia, N (%) | 1038 (25.8) | 446 (21.2) | 592 (30.7) |
| eGFR (mL/min/1.73m2) | 65.7 ± 18.4 | 67.5 ± 18.7 | 63.6 ± 17.8 |
| 45–59.9 mL/min/1.73m2, N (%) | 976 (24.2) | 466 (22.2) | 510 (26.5) |
| 30–44.9 mL/min/1.73m2, N (%) | 397 (9.9) | 187 (8.9) | 210 (10.9) |
| <30 mL/min/1.73m2, N (%) | 97 (2.4) | 39 (1.9) | 58 (3.0) |
| hs-CRP (mg/dL) | 2.36 (1.12–4.94) | 2.28 (1.02–5.01) | 2.44 (1.21–4.86) |
| >3 mg/dL, N (%) | 1664 (41.6) | 854 (40.9) | 810 (42.3) |
| Hydrochlorothiazide, N (%) | 243 (6.0) | 109 (5.2) | 134 (7.0) |
| Thiazide-like, N (%) | 623 (15.5) | 257 (12.2) | 366 (20.0) |
| Loop diuretics, N (%) | 387 (9.6) | 202 (9.6) | 185 (9.6) |
| Spironolactone, N (%) | 469 (11.6) | 226 (10.8) | 243 (12.6) |
| Aspirin, N (%) | 1367 (33.9) | 725 (34.5) | 642 (33.3) |
mean ± standard deviation or median (lower–upper quartile).